BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (the "Shares") (BBIO)

Q: What does CUSIP 10806X102 represent in this 13F holders report?

CUSIP 10806X102 is the security identifier for BBIO - BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (the "Shares") used to aggregate holder disclosures.

Q: How many institutions held BBIO - BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (the "Shares") in Q4 2022?

175 institutional investors reported BBIO - BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (the "Shares") for Q4 2022. Use the holders table for investor-level position and value details.

CUSIP: 10806X102

Q4 2022 13F Holders as of 31 Dec 2022

Security type / class: Equity / Common Stock, par value $0.001 per share (the "Shares")
Shares outstanding: 196,655,058
Total 13F shares: 144,623,389
Share change: -793,190
Total reported value: $1,101,997,850
Put/Call ratio: 41%
Reported price per share: $7.62
Number of holders: 175
Value change: -$14,634,842
Number of buys: 76
Number of sells: 87

Security key

10806X102

Report period

Q4 2022

Institutions

175

Top holders

BBIO full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2023 Previous quarter: Q3 2022 BridgeBio Pharma, Inc. SEC filings BridgeBio Pharma, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 10806X102

Newer quarter: Q1 2023 Previous quarter: Q3 2022

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top reported holders of BBIO - BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (the "Shares") (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

Kohlberg Kravis Roberts &...

13D/G signal

—

Evidence rows

Latest as of

30 Sep 2022

13F Lead comparable stake: 16% Showing 1-6 of 15 holder rows.

Rank 1 holder

Kohlberg Kravis Roberts & Co. L.P.

13F

Ownership: 16%
Position: $308.75M

13F

Rank 2 holder

VIKING GLOBAL INVESTORS LP

13F

Ownership: 14%
Position: $264.61M

13F

Rank 3 holder

VANGUARD GROUP INC

13F

Ownership: 5.1%
Position: $99.44M

13F

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Kohlberg Kravis Roberts & Co. L.P.	13F Company 13F	16%	$308,746,000 31,060,971 shares	—	30 Sep 2022
VIKING GLOBAL INVESTORS LP	13F Company 13F	14%	$264,613,000 26,620,991 shares	—	30 Sep 2022
VANGUARD GROUP INC	13F Company 13F	5.1%	$99,442,000 10,004,271 shares	—	30 Sep 2022
BlackRock Finance, Inc.	13F Company 13F	4.7%	$92,103,000 9,265,868 shares	—	30 Sep 2022
STATE STREET CORP	13F Company 13F	4%	$78,952,000 7,942,811 shares	—	30 Sep 2022
Aisling Capital Management LP	13F Company 13F	3.1%	$60,317,000 6,068,125 shares	—	30 Sep 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

175

144,623,389

Rows available

175

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

^* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders

170

Q4 2022 holders

175

Holder diff

Investor	Q3 2022 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q3 2022 value	Q4 2022 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend